Although the pathological significance of such an increase is not clear, it provides an explanation for the contradiction of the reported upregualtion of TLR7 and TLR9 in but largely normal or even diminished responses to the corresponding ligands for SLE B cells. This evidence concerns the gene TLR9 and systemic lupus erythematosus.